(Q46533455)

22 December 2017

title

Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies (English)

1 reference

22 December 2017

1 reference

Farid Nakhoul

1

1 reference

22 December 2017

Rawi Ramadan

2

1 reference

22 December 2017

Eliyahu Khankin

3

1 reference

22 December 2017

Afif Yaccob

4

1 reference

22 December 2017

Zoya Kositch

5

1 reference

22 December 2017

Moshe Lewin

6

1 reference

22 December 2017

Suheir Assady

7

1 reference

22 December 2017

Zaid Abassi

8

1 reference

22 December 2017

publication date

7 June 2005

1 reference

22 December 2017

American Journal of Physiology - Renal Physiology

published in

1 reference

22 December 2017

volume

289

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

F880-90

1 reference

22 December 2017

Changes in glomerular perm-selectivity induced by angiotensin II imply podocyte dysfunction and slit diaphragm protein rearrangement

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Vasopeptidase inhibitors: an emerging class of cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Review of the immunosuppressant enteric-coated mycophenolate sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

21 January 2018

Vasopeptidase inhibition

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Broadening the spectrum of diseases related to podocin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Mycophenolate mofetil treatment for primary glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Molecular structure-function relationship in the slit diaphragm

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

ACE inhibitors and AT-1-receptor antagonists COOPERATE in non-diabetic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Expression of nephrin in acquired human glomerular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

CD2-associated protein directly interacts with the actin cytoskeleton.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Nephrin in experimental glomerular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Atrial natriuretic peptide increases urinary albumin excretion in men with type 1 diabetes mellitus and established microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Early glomerular filtration defect and severe renal disease in podocin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Progression, remission, regression of chronic renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Combination ACEI and ARB therapy: additional benefit in renoprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00451.2004

10.1152/AJPRENAL.00451.2004

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017